Chemotherapy and Targeted Therapy

A Tumultuous Tenure Ends: Marty Makary Resigns as FDA Commissioner Amid Agency Instability

• Chemotherapy and Targeted Therapy

A Tumultuous Tenure Ends: Marty Makary Resigns as FDA Commissioner Amid Agency Instability

Muslim May 12, 2026 0

In a move that marks the conclusion of one of the most volatile chapters in the history...

Read More Read more about A Tumultuous Tenure Ends: Marty Makary Resigns as FDA Commissioner Amid Agency Instability

New Frontiers in Diabetes Management: Black Ginger Extract Shows Promise in Regulating Muscle Glucose Metabolism

• Chemotherapy and Targeted Therapy

New Frontiers in Diabetes Management: Black Ginger Extract Shows Promise in Regulating Muscle Glucose Metabolism

Nila Kartika Wati May 12, 2026 0

By Medical Science Correspondent A landmark study published in the journal Pharmaceuticals (2026) has shed new light...

Read More Read more about New Frontiers in Diabetes Management: Black Ginger Extract Shows Promise in Regulating Muscle Glucose Metabolism

Innovative Research Unveils Potential for Traditional Chinese Medicine in Modern Depression Treatment

• Chemotherapy and Targeted Therapy

Innovative Research Unveils Potential for Traditional Chinese Medicine in Modern Depression Treatment

Nana May 12, 2026 0

Main Facts: A Breakthrough in Neuropsychiatric Care A groundbreaking study published in the journal Pharmaceuticals (Vol. 19,...

Read More Read more about Innovative Research Unveils Potential for Traditional Chinese Medicine in Modern Depression Treatment

Eli Lilly Escalates U.S. Manufacturing Dominance with $4.5 Billion Lebanon Expansion

• Chemotherapy and Targeted Therapy

Eli Lilly Escalates U.S. Manufacturing Dominance with $4.5 Billion Lebanon Expansion

Suro Senen May 12, 2026 0

By Industry Desk | May 8, 2026 In a move that cements its status as a cornerstone...

Read More Read more about Eli Lilly Escalates U.S. Manufacturing Dominance with $4.5 Billion Lebanon Expansion

New Study Suggests PCSK9 Inhibitors May Lower Risk of Age-Related Macular Degeneration

• Chemotherapy and Targeted Therapy

New Study Suggests PCSK9 Inhibitors May Lower Risk of Age-Related Macular Degeneration

Laily UPN May 12, 2026 0

A groundbreaking retrospective study published in the journal Pharmaceuticals reveals that patients with atherosclerotic cardiovascular disease (ASCVD)...

Read More Read more about New Study Suggests PCSK9 Inhibitors May Lower Risk of Age-Related Macular Degeneration

Weekly Pharma Pulse: Inhibrx Data, Legal Battles, and Regulatory Shifts Shake the Biotech Sector

• Chemotherapy and Targeted Therapy

Weekly Pharma Pulse: Inhibrx Data, Legal Battles, and Regulatory Shifts Shake the Biotech Sector

Muslim May 11, 2026 0

Published: May 11, 2026 The biotechnology landscape experienced a week of significant volatility and strategic realignment, marked...

Read More Read more about Weekly Pharma Pulse: Inhibrx Data, Legal Battles, and Regulatory Shifts Shake the Biotech Sector

New Pharmacokinetic Insights into Chikusetsusaponin IVa for Myocardial Ischemia/Reperfusion Injury

• Chemotherapy and Targeted Therapy

New Pharmacokinetic Insights into Chikusetsusaponin IVa for Myocardial Ischemia/Reperfusion Injury

Lina Hope May 11, 2026 0

A Breakthrough in Cardiovascular Research A recent study published in the journal Pharmaceuticals (Vol. 19, No. 5)...

Read More Read more about New Pharmacokinetic Insights into Chikusetsusaponin IVa for Myocardial Ischemia/Reperfusion Injury

From Biological Barriers to Breakthroughs: The Unlikely Science of Pig Semen in Ocular Oncology

• Chemotherapy and Targeted Therapy

From Biological Barriers to Breakthroughs: The Unlikely Science of Pig Semen in Ocular Oncology

Layla Zulfa May 11, 2026 0

In a remarkable convergence of reproductive biology and ophthalmological innovation, researchers have pioneered a non-invasive treatment for...

Read More Read more about From Biological Barriers to Breakthroughs: The Unlikely Science of Pig Semen in Ocular Oncology

The Strategic Imperative: Why "Ready-Now" Infrastructure is Reshaping Biopharma Site Selection

• Chemotherapy and Targeted Therapy

The Strategic Imperative: Why "Ready-Now" Infrastructure is Reshaping Biopharma Site Selection

Asro May 11, 2026 0

In the high-stakes arena of modern biopharmaceutical manufacturing, the traditional metrics of site selection—primarily tax rates and...

Read More Read more about The Strategic Imperative: Why "Ready-Now" Infrastructure is Reshaping Biopharma Site Selection

New Study Validates Biosimilar Ranibizumab: A Breakthrough for Affordable Retinal Care

• Chemotherapy and Targeted Therapy

New Study Validates Biosimilar Ranibizumab: A Breakthrough for Affordable Retinal Care

Evan Lee Salim May 11, 2026 0

In a major development for global ophthalmology, a comprehensive, multicenter study has provided robust real-world evidence confirming...

Read More Read more about New Study Validates Biosimilar Ranibizumab: A Breakthrough for Affordable Retinal Care